2008

November

• Top 10 Biggest Medical Stories of 2008

• Window Blinds & Shades Recalled After Child Dies

• Duragesic Pain Patch Makers Ordered to Pay Millions to Victims

• Officials Offer Holiday Present Safety Guidelines

• Yamaha Rhino Being Investigated for Dozens of Passenger Deaths

October

• FDA is Ignoring Dangers of Plastic Chemical, Experts Say

• Where Do the Candidates Stand on Prescription Drugs?

• JAMA Backs Plaintiffs’ Rights to Sue Medical Device Makers

• Pfizer to Pay $894 Million to Settle Celebrex and Bextra Suits

• Vioxx Risks Lingered Far Longer Than Previously Known, New Study Finds

• New Mortgage Bailout Plan Shows Importance of Speaking With a Loan-Modification Attorney

September

• Food Origin Labeling Goes Into Effect, Aimed at Curtailing Contamination

• More Regulation Of Heparin is Needed to Avoid Deaths, Injuries

• Researchers Find Less Than Half of FDA Clinical Trial Results Are Published

• Wyeth Concedes that Levine Case is not suitable to rule on broad preemption

• Debate Rages On About Plastic Chemical Bisphenol A: Is It Toxic or Safe?

• Troubles At Lehman Brothers, Washington Mutual Further Rattle Wall Street

• FDA Posts List of Potentially Dangerous Prescription Drugs

August

• U.S. Bans Lead in Children’s Toys: Critics Wonder What Took So Long

• Mark & Associates, P.C. Offering Free Legal Consultations for Hip Patients and Their Families

• Non-Compete Clauses Violate Workers’ Rights, California Supreme Court Rules

• Mark & Associates, P.C. Investigating Reports of Serious Tendon Injuries Fluoroquinolone Antibiotics

July

• Unapproved, “Off-Label” Uses of Botox Cause Patient Deaths and Injuries

• Mark & Associates, P.C. & McGinnis, Lochridge, Kilgore, L.L.P. File Lawsuit Against Botox Maker

June

• Smokers or Pfizer: Who Really Needs Chantix to Succeed?

May

• Digitek Digoxin double thickness pill overdose

• Mark & Associates, P.C. Files Arbitration on Behalf of Bear Stearns Shareholder

April

• Chinese Manufacturing of Pharmaceuticals Puts Patients at Risk

March

• Free Legal Consultations for Bear Stearns Shareholders Who Suffered Losses of $10k or More

• Tysabri Patients Diagnosed With Severe Liver Damage or Melanoma

• Bear Stearns Shareholders Have Legal Options

• Now Evaluating Claims Involving Tysabri Patients Diagnosed With Severe Liver Damage or Melanoma

February

• Judicial Panel on Multi-District Litigation Transfers all Medtronic Sprint Fidelis Cases

• The Supreme Court’s Ruling in Riegel v. Medtronic Will Not Stop the Pursuit of Justice

• Exposing Bayer’s Trasylol Tragedy

• Does the FDA Take Suicide As Seriously as Other Side Effects?

• Adverse Effects of Chantix

• Mesothelioma and Asbestos Exposure Explained

January

• Preemption - the legal defense that puts everyone at risk

• With Blockbusters Coming Off Patent Pfizer Needs Chantix’s Revenue

• Patients with Defective Defibrillator Leads Could Lose Their Right to Sue

2007

December

• Avandia Side Effects Warning

November

• Medtronic Recalls Sprint Fidelis Leads

August

• Hernia Surgery and the Kugel Hernia Mesh Patch

• Gadolinium Based Contrast Agents

May

• Welcome to You Have Rights